stocks Allergan Inc

Valeant and Allergan a 'perfect match': Shareholder
11:38 AM ET Tue, 22 April 2014
One of Valeant's top shareholders on Tuesday threw his support behind its proposed takeover bid for Botox-maker Allergan.
Morning six-pack: What we're reading Tuesday
10:12 AM ET Tue, 22 April 2014
Happy Tuesday. Keep your eye on the prize and watch out for the activist investor looking to snag your Morning Six-Pack.
Jim Cramer: This looks like a 'legal scam'
3:10 PM ET Tue, 22 April 2014
The bid for botox producer Allergan reveals the "legal scam" that the U.S. tax code has become, CNBC's Jim Cramer says.
Valeant, Ackman stage $45 bln bid for Allergan
9:49 AM ET Tue, 22 April 2014
Valeant Pharmaceuticals and Bill Ackman are proposing a cash-and-stock deal for Allergan that could be worth about $45 billion.
Close look at Allergan bid
10:13 AM ET Mon, 28 April 2014
The "Squawk on the Street" news team discuss the legality of activist investor Bill Ackman backing the bid of Valeant Pharmaceuticals to acquire Allergan.
Wall Street to focus on key earnings, M&A
9:16 AM ET Tue, 22 April 2014
U.S. stock index futures pointed to a lower open on Tuesday, ahead of first-quarter earnings early in the day from three Dow-listed companies.
Early movers: CMCSA, NFLX, GM, PFE, NVS & more
7:58 AM ET Tue, 22 April 2014
Some of the names on the move ahead of the open.
Asia shares mixed; China Resources affiliates plunge
6:56 AM ET Tue, 22 April 2014
Asian equities were mixed on Tuesday as investors were cautious about the prospect of further U.S. sanctions on Russia.
Pharma M&A is back—Can it cure the sector’s ills?
7:18 AM ET Tue, 22 April 2014
Pharmaceutical industry observers have been waiting for a rush of deals for months - and they might have finally arrived.
Value stocks to stay in vogue, as momentum fades
5:41 PM ET Mon, 21 April 2014
With the wipeout in growth stocks, many investors turned their attention to big-cap and value names, and the trend is expected to continue.
After-hours buzz: Allergan, Valeant, Netflix & More
10:09 AM ET Wed, 23 April 2014
Headlines after the bell.
Ackman, Valeant pursuing takeover of Allergan
6:17 PM ET Mon, 21 April 2014
Activist investor William Ackman of Pershing Square Capital and Valeant Pharmaceuticals International are said to be pursuing a takeover of Allergan.
Ackman's pursuit of Allergan
5:09 PM ET Mon, 21 April 2014
Discussing Bill Ackman's partnership with Valeant to pursue a takeover of Allergan, with CNBC contributor Herb Greenberg and CNBC's Meg Tirrell.
Ackman, Valeant pursue takeover of Allergan: DJ
4:44 PM ET Mon, 21 April 2014
CNBC's Seema Mody reports according to the Dow Jones, activist investors Bill Ackman is teaming up with Valeant to pursue a takeover of Allergan. Anthony Scaramucci, SkyBridge Capital, provides insight.
Cramer’s homework: Buy vaccine maker for ‘spec’?
6:45 PM ET Fri, 28 March 2014
When Jim Cramer tells a caller that he needs to do homework he's not kidding. Here's his research.
Midday movers: Sony; Safeway, Twitter & More
7:33 PM ET Tue, 18 Feb 2014
Some of Tuesday's midday movers:
Early movers: BAC, GM, CMCSA, AAPL, AET & more
7:50 AM ET Wed, 15 Jan 2014
Some of the names on the move ahead of the open.
Cramer: Have faith in these 5 CEOs
6:14 PM ET Tue, 14 Jan 2014
Not all CEOs are created equal. Who should you believe in? Jim Cramer has faith in the following 5 top executives.
Midday movers: Herbalife, Eli Lilly, Cray & More
5:14 PM ET Tue, 7 Jan 2014
Some of Tuesday's midday movers:
Data will be the key as Fed meeting starts
9:36 PM ET Mon, 28 Oct 2013
As the Fed begins its two-day policy meeting Tuesday, markets will get a look at how consumers behaved just before the government shut down.

« First

Next » | Last »

var mps=mps||{}; mps._queue=mps._queue||{}; mps._queue.gptloaded=mps._queue.gptloaded||[]; mps._queue.gptloaded.push(function() { (mps && mps.insertAd && mps.insertAd('#dart_wrapper_badgec', 'badgec')); }); stocks Allergan Inc

stocks Allergan Inc